TY - JOUR
T1 - Outcomes Research in Cardiovascular Imaging
T2 - Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute
AU - Douglas, Pamela S.
AU - Taylor, Allen
AU - Bild, Diane
AU - Bonow, Robert
AU - Greenland, Philip
AU - Lauer, Michael
AU - Peacock, Frank
AU - Udelson, James
N1 - Funding Information:
Dr. Greenland served as a consultant to GE and Toshiba, and received a small honorarium from Pfizer for a role on a Visiting Professor Selection Committee. Dr. Peacock is on the Scientific Advisory Board, or is a consultant or speaker for Abbott, Beckman Coulter, Biosite, Heartscape, Inovise, Inverness, Ortho Clinical Diagnostics, and The Medicine's Company. He has received research grants from Abbott, BAS, Biosite, Brahms, Heartscape, Inovise, Inverness, EKR, and the Medicine's Company. Also, he has an ownership interest in Vital Sensors. Dr. Udelson is co-PI of the ROMICAT-2 trial, sponsored by the American College of Radiology Imaging Network (ACRIN). He has received research funding and has served as a consultant to Lantheus Medical Imaging and Molecular Insight Pharmaceuticals. Drs. Douglas and Taylor are co-first authors. Reviewers for this article are: Stephan Achenbach, MD, Associate Editor, JACC: Cardiovascular Imaging; Thomas Marwick, MBBS, PhD, Associate Editor, JACC: Cardiovascular Imaging; Christopher Kramer, MD, Associate Editor, JACC: Cardiovascular Imaging; Vasken Dilsizian, MD, Associate Editor, JACC: Cardiovascular Imaging.
PY - 2009/7
Y1 - 2009/7
N2 - In July of 2008, the National Heart, Lung, and Blood Institute convened experts in noninvasive cardiovascular imaging, outcomes research, statistics, and clinical trials to develop recommendations for future randomized controlled trials of the use of imaging in: 1) screening the asymptomatic patient for coronary artery disease; 2) assessment of patients with stable angina; 3) identification of acute coronary syndromes in the emergency room; and 4) assessment of heart failure patients with chronic coronary artery disease with reduced left ventricular ejection fraction. This study highlights several possible trial designs for each clinical situation.
AB - In July of 2008, the National Heart, Lung, and Blood Institute convened experts in noninvasive cardiovascular imaging, outcomes research, statistics, and clinical trials to develop recommendations for future randomized controlled trials of the use of imaging in: 1) screening the asymptomatic patient for coronary artery disease; 2) assessment of patients with stable angina; 3) identification of acute coronary syndromes in the emergency room; and 4) assessment of heart failure patients with chronic coronary artery disease with reduced left ventricular ejection fraction. This study highlights several possible trial designs for each clinical situation.
KW - Cardiovascular imaging
KW - Chest pain diagnosis
KW - Clinical trials
UR - http://www.scopus.com/inward/record.url?scp=67649089040&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67649089040&partnerID=8YFLogxK
U2 - 10.1016/j.echo.2009.05.026
DO - 10.1016/j.echo.2009.05.026
M3 - Article
C2 - 19560655
AN - SCOPUS:67649089040
VL - 22
SP - 766
EP - 773
JO - Journal of the American Society of Echocardiography
JF - Journal of the American Society of Echocardiography
SN - 0894-7317
IS - 7
ER -